Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Cloning and expression of the murine Elf-1 cDNA.

Davis JN, Roussel MF.

Gene. 1996 Jun 1;171(2):265-9.

PMID:
8666284
2.

Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts.

Herrera RE, Sah VP, Williams BO, Mäkelä TP, Weinberg RA, Jacks T.

Mol Cell Biol. 1996 May;16(5):2402-7.

3.

Mammalian G1 cyclins.

Sherr CJ.

Cell. 1993 Jun 18;73(6):1059-65. Review. No abstract available.

PMID:
8513492
4.

Cyclin D1 is a nuclear protein required for cell cycle progression in G1.

Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G.

Genes Dev. 1993 May;7(5):812-21.

5.

Physical interaction of the retinoblastoma protein with human D cyclins.

Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA.

Cell. 1993 May 7;73(3):499-511.

PMID:
8490963
6.
7.

The Ets family of transcription factors.

Wasylyk B, Hahn SL, Giovane A.

Eur J Biochem. 1993 Jan 15;211(1-2):7-18. Review. Erratum in: Eur J Biochem 1993 Aug 1;215(3):907.

8.

The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit.

Durfee T, Becherer K, Chen PL, Yeh SH, Yang Y, Kilburn AE, Lee WH, Elledge SJ.

Genes Dev. 1993 Apr;7(4):555-69.

9.

E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.

Flemington EK, Speck SH, Kaelin WG Jr.

Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):6914-8.

10.

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.

Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM.

Cell. 1993 May 7;73(3):487-97.

PMID:
8343202
11.

Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ.

Genes Dev. 1993 Aug;7(8):1559-71.

12.
13.
14.

DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.

Lukas J, Müller H, Bartkova J, Spitkovsky D, Kjerulff AA, Jansen-Dürr P, Strauss M, Bartek J.

J Cell Biol. 1994 May;125(3):625-38.

15.

DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein.

Inaba T, Shapiro LH, Funabiki T, Sinclair AE, Jones BG, Ashmun RA, Look AT.

Mol Cell Biol. 1994 May;14(5):3403-13.

16.

Identification of G1 kinase activity for cdk6, a novel cyclin D partner.

Meyerson M, Harlow E.

Mol Cell Biol. 1994 Mar;14(3):2077-86.

17.

D-type cyclin-dependent kinase activity in mammalian cells.

Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY.

Mol Cell Biol. 1994 Mar;14(3):2066-76.

18.

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.

Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y.

Genes Dev. 1994 Dec 15;8(24):2939-52.

19.

Solution structure of a specific DNA complex of the Myb DNA-binding domain with cooperative recognition helices.

Ogata K, Morikawa S, Nakamura H, Sekikawa A, Inoue T, Kanai H, Sarai A, Ishii S, Nishimura Y.

Cell. 1994 Nov 18;79(4):639-48.

PMID:
7954830
20.

G1 phase progression: cycling on cue.

Sherr CJ.

Cell. 1994 Nov 18;79(4):551-5. Review. No abstract available.

PMID:
7954821
Items per page

Supplemental Content

Support Center